EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aberrant phase separation from a rare ABI3 mutation drives microglial dysfunction and Alzheimer's risk

Shengnan Li, Jiongtong Lu, Kaixing Zeng, Xingyu Lu, Jiahao Zhang, Sifan Feng, Chunmei Liang, Yujie Cai, Shi Yao, Qing Huang, Guocong Liang, Rui Chen und 11 weitere

Alzheimer's & Dementia · 2026

DOI: 10.1002/alz.71812 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Shengnan Li und 22 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neurology, Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases, Affiliated Hospital of Guangdong Medical University, Z…. Hauptthemen laut MEDLINE: Microglia, Alzheimer Disease, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Scientific Research Start-up Fund for High-level Talents of the Affiliated Hospital of Guangdong Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Although the ABI3 S209F variant is a recognized genetic risk for Alzheimer's disease (AD), its pathogenic mechanism remains elusive. METHODS Using AD mouse models (amyloid precursor protein/presenilin 1 [APP/PS1] transgenic mice, 5×familial Alzheimer's disease (5×FAD) transgenic mice) with microglia‐specific knockdown of Abelson‐interactor family member 3 ( ABI3) or expression of the wild‐type or S209F mutant, we assessed disease pathology. Primary mouse microglia and HMC3 cells were used to examine ABI3 function and S209F effects. Liquid–liquid phase separation (LLPS) properties were characterized in cellular systems and with recombinant proteins. RESULTS ABI3 was highly expressed in AD microglia. ABI3 enhanced microglial clustering around amyloid beta (Aβ) plaques, promoted Aβ clearance, and ameliorated cognitive decline, whereas S209F abolished these effects. Mechanistically, ABI3 undergoes LLPS essential for microglial migration and phagocytosis. The S209 residue lies within an intrinsic disordered region, and S209F disrupts phosphorylation‐dependent LLPS, thereby impairing microglial functions. DISCUSSION The AD‐associated ABI3 S209F variant drives pathogenesis by disrupting LLPS, causing microglial dysfunction. Enhancing ABI3 phase separation represents a potential therapeutic strategy to boost microglial activity against Aβ pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaAlzheimer DiseaseAdaptor Proteins, Signal TransducingAnimalsMice, TransgenicPhase SeparationMiceMutationDisease Models, AnimalHumansPlaque, AmyloidAmyloid beta-PeptidesAmyloid beta-Protein PrecursorPresenilin-1

Stichwörter der Autor:innen

Abelson‐interactor family member 3Alzheimer's diseaseamyloid betaliquid–liquid phase separationmicroglia

Substanzen

Adaptor Proteins, Signal TransducingAmyloid beta-PeptidesAmyloid beta-Protein PrecursorPresenilin-1

Autor:innen und Institutionen

  • Institute of Neurology, Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
  • The Marine Biomedical Research Institute of Guangdong, School of Ocean and Tropical Medicine, Guangdong Medical University, Zhanjiang, China.
  • Guangdong Laboratory for Lingnan Modern Agriculture, State Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources, Guangdong Provincial Key Laboratory of Plant Molecular Breeding, South China A…
  • Institute of Neuroscience, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
  • Department of Human Anatomy, Histology and Embryology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • Scientific Research Start-up Fund for High-level Talents of the Affiliated Hospital of Guangdong Medical University
  • National-Level Talent Cultivation Funding Program of The Affiliated Hospital of Guangdong Medical University
  • Cultivation Project of Youth Science Fund of National Natural Science Foundation of China at Affiliated Hospital of Guangdong Medical University
  • Lingang Laboratory
  • Zhanjiang Science and Technology Plan: Talent Enclave Special Project

Zitieren

APA

Li, S., Lu, J., Zeng, K., Lu, X., Zhang, J., Feng, S., Liang, C., Cai, Y., Yao, S., Huang, Q., Liang, G., Chen, R., Li, L., Ma, F., Xing, J., Ouyang, C., Luo, L., Wang, J., Li, Y., …, & Cui, L. (2026). Aberrant phase separation from a rare ABI3 mutation drives microglial dysfunction and Alzheimer's risk. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71812

Vancouver

Li S, Lu J, Zeng K, Lu X, Zhang J, Feng S, et al. Aberrant phase separation from a rare ABI3 mutation drives microglial dysfunction and Alzheimer's risk. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71812

BibTeX
@article{Li2026,
  author = {Li, Shengnan and Lu, Jiongtong and Zeng, Kaixing and Lu, Xingyu and Zhang, Jiahao and Feng, Sifan and Liang, Chunmei and Cai, Yujie and Yao, Shi and Huang, Qing and Liang, Guocong and Chen, Rui and Li, Li and Ma, Fubin and Xing, Jiawei and Ouyang, Chaoyue and Luo, Lv and Wang, Jiaying and Li, You and He, Shengbo and Zhao, Yuanyuan and Wang, Yan and Cui, Lili},
  title = {Aberrant phase separation from a rare ABI3 mutation drives microglial dysfunction and Alzheimer's risk},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  doi = {10.1002/alz.71812}
}
Kostenlos starten →